CN102988682A - Oral liquid for tonifying kidney and spleen and preventing and treating osteoporosis - Google Patents
Oral liquid for tonifying kidney and spleen and preventing and treating osteoporosis Download PDFInfo
- Publication number
- CN102988682A CN102988682A CN201210391177XA CN201210391177A CN102988682A CN 102988682 A CN102988682 A CN 102988682A CN 201210391177X A CN201210391177X A CN 201210391177XA CN 201210391177 A CN201210391177 A CN 201210391177A CN 102988682 A CN102988682 A CN 102988682A
- Authority
- CN
- China
- Prior art keywords
- parts
- oral liquid
- preventing
- parched
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention provides oral liquid for tonifying kidney and spleen and preventing and treating osteoporosis. Concentrated decoction comprising the following components in parts by weight: 8 to 15 parts of astragalus, 8 to 12 parts of codonopsis pilosula, 8 to 12 parts of fried bighead atractylodes rhizome, and 8 to 12 parts of fried yam contains 30 to 60 weight parts of chondroitin sulfate. The invention also provides the oral liquid for tonifying kidney and spleen and preventing and treating osteoporosis, which is characterized by comprising the following components in every 100 parts of water: 10 to 50 parts of the oral liquid, 10 to 30 parts of honey, 0.01 to 0.03 part of sodium alginate, and proper natural edible essence. The product has good effect of preventing and treating osteoporosis.
Description
Technical field
The invention belongs to field of medicaments, be specifically related to a kind of Yishen Jianpi and prevent and treat osteoporotic oral liquid.
Background technology
Osteoporosis (osteoporosis) is a kind of systemic osteopathia, it is characterized in that the bone amount descends and the fine structure of bone destroys, the fragility that shows as bone increases, thereby the danger of fracture greatly increases, even also fracture easily in slight wound or the atraumatic situation.Osteoporosis is a kind of chronic disease due to multifactor.Before fracture occurs, usually without Special Clinical Manifestation.The women is more than the male for this disease, is common in postmenopausal women and old people.Along with the increase of China's aging population, the osteoporosis sickness rate is in ascendant trend, all is a health problem that merits attention in China and even the whole world.
Motherland's medical science think primary disease generation, the development and " kidney qi " closely related, " the contrary opinion of transferring of Plain Questions " said: " kidney is not given birth to; then marrow can not be expired ", " Plain Questions six joints are hidden and resembled opinion " said: " kidney person, the master stings the dominator of storing essence; smart part is also; its Hua Zaifa, and it fills at bone " ", therefore its employing invigorating the kidney and strengthening the bones, invigorating the spleen and benefiting QI, promoting blood circulation to remove obstruction in the collateral are all obtained preferably effect.
The traditional Chinese medical science adopts differentiation of symptoms and signs for classification of syndrome, for different types, adopts the prescription of suiting the medicine to the illness.As adopting the prescription of nourishing the liver and kidney, bone and muscle strengthening for deficiency of the liver and kidney, such as square medicine: chien pu hu chien wan: 2 parts of Colla Plastri Testudinis, 2 parts of Colla cornus cervis, 2 parts of Tigris shins (now use Os Canitis generation), 2 parts of Radix Polygoni Multiflori, 2 parts of Radix Cyathulaes, 2 parts of the Cortexs Eucommiae, 2 parts of Herba Cynomoriis, 2 parts of Radix Angelicae Sinensis, 2 parts of Radix Rehmanniae Preparata, 2 parts of Radix Clematidis, 1 part of Cortex Phellodendri, 1 part of Radix Ginseng, 1 part of Rhizoma Et Radix Notopterygii, 1 part of the Radix Paeoniae Alba, 1 part of the Rhizoma Atractylodis Macrocephalae, 1.5 parts of great river Radix Aconiti Lateralis Preparatas, Mel is an amount of.Grind and be smalls, refined honey ball such as Semen phaseoli radiati are large).Every 10 grams that take, light salt brine send down every day 2～3 times on an empty stomach.
Adopt the prescription of Yishen Jianpi for yang deficiency of spleen and stomache, such as square medicine: SHENLING BAISHU SAN is closed Yougui Yin, the kidney-Yang-Reinkforcing Decotion: Semen Nelumbinis (peeling) 500 grams, and Semen Coicis 50 restrains, contracting Fructus Amomi 50 grams, Radix Platycodonis (stir-fry makes buff) 50 grams, (Sucus Zingberis soaks Semen Lablab Album, peeling, little stir-fry) 75 grams, Poria 100 grams, Radix Ginseng 100 grams, Radix Glycyrrhizae (stir-fry) 100 grams, the Rhizoma Atractylodis Macrocephalae 100 grams, Rhizoma Dioscoreae 100 grams.Grind and be smalls, each serving 6 grams, Fructus Jujubae is fried in shallow oil soup and is taken.
Adopt the prescription of blood-activating and qi-promoting, removing obstruction in the collateral to relieve pain for qi stagnation and blood stasis type, such as square medicine: Traditional Chinese medicine decoction for treating-ache and expelling atagnate: Radix Gentianae Macrophyllae 3 grams, Rhizoma Chuanxiong 6 grams, Semen Persicae 9 grams, Flos Carthami 9 grams, Radix Glycyrrhizae 6 grams, Rhizoma Et Radix Notopterygii 3 grams, Myrrha 6 grams, Radix Angelicae Sinensis 9 grams, Oletum Trogopterori (stir-fry) 6 grams, Rhizoma Cyperi 3 grams, Radix Achyranthis Bidentatae 9 grams, Pheretima 6 grams.Be decocted in water for oral dose, it is greasy to avoid cold and uncooked food, and is not taken by pregnant women.
Chondroitin sulfate (Chondroitin sulfate) is present in the animal cartilage in a large number, is the acid mucopolysaccharide that extracts preparation from animal tissue.Chondroitin sulfate is a kind of of glycosaminoglycans, by D-glucuronic acid and N-acetylamino galactosamine with β-1, the polysaccharide that the repetition disaccharide unit that the 4-glycosidic bond is formed by connecting forms, and at C-4 position or the C-6 position hydroxyl of N-acetylamino galactosamine Sulfation occurs, be mainly used in arthritis, eye drop etc., studies show that chondroitin sulfate can promote osteoblast hypertrophy and new bone formation." the sulfated compound chrondroitin is to the therapeutical effect of rats with osteoporosis for scientific and technical literature
" (Liu Xiuju, Zhang Jixian, Mu Zhongxiang etc., " food and pharmaceutical " 05 phase in 2008) study the effect that the sulfated compound chrondroitin is treated the rats with osteoporosis of Induced by Retinoic Acid, the result shows, compare with model group, the sulfated compound chrondroitin is high, middle dosage group can significantly increase rat body weight, improves bone mineral content and bone density, reduces serum alkaline phosphatase (ALP) level, and can significantly improve the biomechanical parameter of femur, rats with osteoporosis there is therapeutical effect.
There is no at present the drug regimen of Chinese medicine and chondroitin sulfate is studied.
Summary of the invention
The invention provides a kind of Yishen Jianpi and prevent and treat osteoporotic oral liquid, adopt Chinese medicine and the chondroitin sulfate combined treatment osteoporosis of Yishen Jianpi for yang deficiency of spleen and stomache.
The concrete technical scheme of the present invention is as follows:
A kind of Yishen Jianpi is prevented and treated osteoporotic oral liquid, Radix Astragali 8-15 part of weight portion, and Radix Codonopsis 8-12 part, Rhizoma Atractylodis Macrocephalae (parched) 8-12 part is contained chondroitin sulfate 30-60 part in the concentrated decotion of Rhizoma dioscoreae (parched) 8-12 part.
Above-mentioned oral liquid, weight portion are 15 parts of the Radixs Astragali of weight portion, 12 parts of Radix Codonopsis, and 12 parts of Rhizoma Atractylodis Macrocephalae (parched)s contain 60 parts of chondroitin sulfate in the concentrated decotion that Rhizoma dioscoreae (parched) is 12 parts.
A kind of Yishen Jianpi is prevented and treated osteoporotic oral liquid, it is characterized in that allocating in per 100 parts of water above-mentioned oral liquid 10-50 part, 10～30 parts of Mel, and 0.01～0.03 part of sodium alginate, natural edible essence is an amount of.
The specific embodiment
Below in conjunction with instantiation technical scheme of the present invention is described further, helps to understand the present invention, but do not limit content of the present invention.
Embodiment 1
Take by weighing Radix Astragali 8g, Radix Codonopsis 8g, Rhizoma Atractylodis Macrocephalae (parched) 8g, Rhizoma dioscoreae (parched) 8g pulverizes, and decocts with water 2 times, each 320ml, decocted 1 hour, medicinal liquid merges, and filters, it is 1.05-1.15(50-60 ℃ that filtrate is concentrated into relative density), add ethanol to the 50%-80% precipitate with ethanol, left standstill 24 hours, filter, filtrate decompression Distillation recovery ethanol, being concentrated into relative density is 1.10-1.25(50-60 ℃), add the 30g chondroitin sulfate and be stirred to dissolving.
Embodiment 2
Take by weighing Radix Astragali 12g, Radix Codonopsis 10g, Rhizoma Atractylodis Macrocephalae (parched) 10g, Rhizoma dioscoreae (parched) 10g pulverizes, and decocts with water 2 times, each 420ml decocted 1 hour, and medicinal liquid merges, filter, it is 1.05-1.15(50-60 ℃ that filtrate is concentrated into relative density), add ethanol to the 50%-80% precipitate with ethanol, left standstill 24 hours, and filtered filtrate decompression Distillation recovery ethanol, being concentrated into relative density is 1.10-1.25(50-60 ℃), add the 45g chondroitin sulfate and be stirred to dissolving.
Embodiment 3
Take by weighing Radix Astragali 15g, Radix Codonopsis 12g, Rhizoma Atractylodis Macrocephalae (parched) 12g, Rhizoma dioscoreae (parched) 12g pulverizes, and decocts with water 2 times, each 510ml decocted 1 hour, and medicinal liquid merges, filter, it is 1.05-1.15(50-60 ℃ that filtrate is concentrated into relative density), add ethanol to the 50%-80% precipitate with ethanol, left standstill 24 hours, and filtered filtrate decompression Distillation recovery ethanol, being concentrated into relative density is 1.10-1.25(50-60 ℃), add the 60g chondroitin sulfate and be stirred to dissolving.
Embodiment 4
Get the drug solution 10g that embodiment 1 method makes, be dissolved in the 100g water, Mel 10g, sodium alginate 0.01g, natural essence is an amount of, and mix and blend namely gets product.
Embodiment 5
Get the drug solution 30g that embodiment 2 methods make, be dissolved in the 100g water, Mel 20g, sodium alginate 0.02g, natural essence is an amount of, and mix and blend namely gets product.
Embodiment 6
Get the drug solution 50g that embodiment 3 methods make, be dissolved in the 100g water, Mel 30g, sodium alginate 0.03g, natural essence is an amount of, and mix and blend namely gets product.
Claims (3)
1. a Yishen Jianpi is prevented and treated osteoporotic oral liquid, it is characterized in that Radix Astragali 8-15 part of weight portion, Radix Codonopsis 8-12 part, and Rhizoma Atractylodis Macrocephalae (parched) 8-12 part is contained chondroitin sulfate 30-60 part in the concentrated decotion of Rhizoma dioscoreae (parched) 8-12 part.
2. oral liquid as claimed in claim 1 is characterized in that comprising that weight portion is 15 parts of the Radixs Astragali of weight portion, 12 parts of Radix Codonopsis, and 12 parts of Rhizoma Atractylodis Macrocephalae (parched)s contain 60 parts of chondroitin sulfate in the concentrated decotion that Rhizoma dioscoreae (parched) is 12 parts.
3. a Yishen Jianpi is prevented and treated osteoporotic oral liquid, it is characterized in that allocating in per 100 parts of water oral liquid 10-50 part as claimed in claim 1,10～30 parts of Mel, and 0.01～0.03 part of sodium alginate, natural edible essence is an amount of.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210391177XA CN102988682A (en) | 2012-10-16 | 2012-10-16 | Oral liquid for tonifying kidney and spleen and preventing and treating osteoporosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210391177XA CN102988682A (en) | 2012-10-16 | 2012-10-16 | Oral liquid for tonifying kidney and spleen and preventing and treating osteoporosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102988682A true CN102988682A (en) | 2013-03-27 |
Family
ID=47918113
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210391177XA Pending CN102988682A (en) | 2012-10-16 | 2012-10-16 | Oral liquid for tonifying kidney and spleen and preventing and treating osteoporosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102988682A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1466976A (en) * | 2002-07-11 | 2004-01-14 | 武汉健民药业集团股份有限公司 | Medicine for preventing and curing rachitis and osteoporosis and method for preparing the same |
| CN101991716A (en) * | 2009-08-26 | 2011-03-30 | 王新祥 | New application of pharmaceutical composition of vital energy benefiting and smart decoction and the like in prevention and cure of osteoporosis |
-
2012
- 2012-10-16 CN CN201210391177XA patent/CN102988682A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1466976A (en) * | 2002-07-11 | 2004-01-14 | 武汉健民药业集团股份有限公司 | Medicine for preventing and curing rachitis and osteoporosis and method for preparing the same |
| CN101991716A (en) * | 2009-08-26 | 2011-03-30 | 王新祥 | New application of pharmaceutical composition of vital energy benefiting and smart decoction and the like in prevention and cure of osteoporosis |
Non-Patent Citations (4)
| Title |
|---|
| 刘秀菊等: "复方硫酸软骨素对大鼠骨质疏松症的治疗作用", 《食品与药品》, vol. 10, no. 05, 10 May 2008 (2008-05-10) * |
| 曹译等: "鹿茸硫酸软骨素蛋白聚糖的分离纯化研究", 《生物学杂志》, vol. 23, no. 05, 25 October 2006 (2006-10-25), pages 30 - 2 * |
| 杨红云等: "骨质疏松症中医辨证分型与治疗松症临床研究", 《现代中西医结合杂志》, vol. 21, no. 19, 31 July 2012 (2012-07-31) * |
| 王军等: "补肾为主治疗骨质疏松症", 《云南中医学院学报》, vol. 22, no. 02, 20 June 1999 (1999-06-20) * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103393879B (en) | Traditional Chinese medicine composition for treating liver and kidney deficiency | |
| CN103356944B (en) | A kind of Chinese medicine composition for the treatment of anemia | |
| CN102940785B (en) | Traditional Chinese medicine composition for treating vertigo | |
| CN101757312A (en) | Chinese medicine preparation for treating thrombocytopenia | |
| CN102988444B (en) | Preparation method of blood circulation promoting and meridian obstruction removing pill for preventing and treating osteoporosis | |
| CN102973760A (en) | Preparation method of oral liquid capable of tonifying kidney and preventing and curing osteoporosis | |
| CN102988447A (en) | Preparation method of oral liquid for promoting blood circulation to remove meridian obstruction and preventing and treating osteoporosis | |
| CN102988680A (en) | Preparation method of medicinal composition for tonifying kidney and spleen, preventing and treating osteoporosis | |
| CN103041333B (en) | Traditional Chinese medicine composition for treating gastritis | |
| CN103028076B (en) | Traditional Chinese medicine composition for treating liver cirrhosis | |
| CN103041335B (en) | Traditional Chinese medicine composition for treating gastralgia | |
| CN103041334B (en) | Traditional Chinese medicine composition for treating abdominal distension | |
| CN1061846C (en) | Traditional Chinese medicine prescription for tonifying the kidney reinforcing the spleen and nourishing the blood and preparation process | |
| CN105477619A (en) | Traditional Chinese medicine composition for treating delayed menorrhea | |
| CN102988682A (en) | Oral liquid for tonifying kidney and spleen and preventing and treating osteoporosis | |
| CN102988445A (en) | Blood circulation promoting and meridian obstruction removing pill for preventing and treating osteoporosis | |
| CN101703660B (en) | Anti-aging medicament | |
| CN101181516B (en) | Chinese medicine prescription orally taken for curing leukaemia | |
| CN102973709A (en) | Oral liquid capable of tonifying kidney and strengthening bone, and preventing and curing osteoporosis | |
| CN103006737A (en) | Oral liquid used for promoting blood circulation to remove meridian obstruction and preventing and treating osteoporosis | |
| CN102988679A (en) | Medicinal composition for tonifying kidney and spleen and preventing and treating osteoporosis | |
| CN102988580A (en) | Preparation method of oral liquid for tonifying kidney, strengthening bone and preventing osteoporosis | |
| CN103816470A (en) | Traditional Chinese medicine composition for treating anorexia | |
| CN102988446A (en) | Medicinal composition for promoting blood circulation to remove meridian obstruction and preventing and treating osteoporosis | |
| CN102988578A (en) | Medicinal composition for tonifying kidney, strengthening bone and preventing osteoporosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20130327 |